Our research suggests that Ba/F3 cells accumulate mutations at an atypical frequency, and these mutations facilitate simultaneous adaptation and “addiction” to introduced transgenes. We further believe that this mutational predisposition contributes to the ability of Ba/F3 cells to readily develop resistance following addition of a transgene-targeting inhibitor.